ID
35140
Description
Study ID: 102970 Clinical Study ID: 102970 Study Title: A 52-week Efficacy and Safety Study to Compare the Effect of Three Dosage Strengths of Fluticasone Furoate/GW642444 Inhalation Powder With GW642444 on the Annual Rate of Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01017952 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: GW642444 Inhalation Powder; FF/GW642444 Inhalation Powder Trade Name: Fluticasone Furoate;Fluticasone Propionate;Fluticasone Propionate/Salmeterol;Salmeterol;Vilanterol Study Indication: Pulmonary Disease, Chronic Obstructive
Mots-clés
Versions (1)
- 19/02/2019 19/02/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
19 de fevereiro de 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Effect of Fluticasone Furoate/GW642444 Inhalation Powder With GW642444 on Annual Rate of Exacerbations in Subjects with COPD; 102970
Early Withdrawal
- StudyEvent: ODM
Description
Candidiasis Examination
Alias
- UMLS CUI-1
- C0006840
- UMLS CUI-2
- C4321457
Description
Oropharyngeal Candidiasis, Evidence
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0919659
- UMLS CUI [1,2]
- C3887511
Description
Oropharyngeal Candidiasis, Taking of swab
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0919659
- UMLS CUI [1,2]
- C0563454
Description
Oropharyngeal Candidiasis, Taking of swab, Result
Type de données
text
Alias
- UMLS CUI [1,1]
- C0919659
- UMLS CUI [1,2]
- C0563454
- UMLS CUI [1,3]
- C1274040
Description
Smoking Status
Alias
- UMLS CUI-1
- C1519386
Description
Smoking Status, Changed status
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1519386
- UMLS CUI [1,2]
- C0443172
Description
Smoking Status, Changed status
Type de données
text
Alias
- UMLS CUI [1,1]
- C1519386
- UMLS CUI [1,2]
- C0443172
Description
Smoking Status, Changed status, Date in time
Type de données
date
Alias
- UMLS CUI [1,1]
- C1519386
- UMLS CUI [1,2]
- C0443172
- UMLS CUI [1,3]
- C0011008
Description
Date of Visit/Assessment
Alias
- UMLS CUI-1
- C1320303
- UMLS CUI-2
- C2985720
Description
Electronically Transferred Lab Data
Alias
- UMLS CUI-1
- C0022885
Description
Laboratory Procedures, Sampling, Date in time
Type de données
date
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C0870078
- UMLS CUI [1,3]
- C0011008
Description
Laboratory Procedures, Sampling, Not done
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C0870078
- UMLS CUI [1,3]
- C1272696
Description
Liver Events Assessment
Alias
- UMLS CUI-1
- C0023884
- UMLS CUI-2
- C0877248
- UMLS CUI-3
- C0220825
Description
Pre-Dose Vital Signs
Alias
- UMLS CUI-1
- C0518766
- UMLS CUI-2
- C0439565
Description
Systolic Pressure
Type de données
integer
Unités de mesure
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Description
Diastolic blood pressure
Type de données
integer
Unités de mesure
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Description
Heart rate
Type de données
integer
Unités de mesure
- bpm
Alias
- UMLS CUI [1]
- C0018810
Similar models
Early Withdrawal
- StudyEvent: ODM
C4321457 (UMLS CUI-2)
C3887511 (UMLS CUI [1,2])
C0563454 (UMLS CUI [1,2])
C0563454 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C0443172 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C2985720 (UMLS CUI-2)
C2985720 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0870078 (UMLS CUI [1,2])
C1272696 (UMLS CUI [1,3])
C0877248 (UMLS CUI-2)
C0220825 (UMLS CUI-3)
C0022885 (UMLS CUI [1,2])
C2746065 (UMLS CUI [1,3])
C0243161 (UMLS CUI [1,4])
Aucun commentaire